Lansford E. Gordon
Known title: DirectorCIK: 0001701216
Lansford E. Gordon's purchase track record
Lansford E. Gordon has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/1/2023 | UMBF | $104K | +18.5% | +5.5% | -0.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| UMBF | ▲ Buy | Grant | 116 | $15K | 5/1/2026 | View on chart |
| UMBF | ▲ Buy | Grant | 786 | $100K | 1/30/2026 | View on chart |
| UMBF | ▲ Buy | Grant | 678 | $80K | 1/31/2025 | View on chart |
| UMBF | ▲ Buy | Grant | 790 | $65K | 2/2/2024 | View on chart |
| UMBF | ▲ Buy | Open Market | 1,700 | $104K | 5/1/2023 | View on chart |
| UMBF | ▲ Buy | Grant | 739 | $65K | 1/27/2023 | View on chart |
| UMBF | ▲ Buy | Grant | 610 | $60K | 1/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
UMB Financial sees price target cuts from JP Morgan, Wells Fargo, Morgan Stanley
Three major banks recently lowered their price targets for UMB Financial, with JP Morgan and Wells Fargo cutting theirs to $160 and $147 respectively. Morgan Stanley also reduced its target to $182 while maintaining an Overweight rating. These adjustments provide a new baseline for the stock's valuation, which currently trades near its 52-week low.
UMB Financial sees price target cuts from JP Morgan, Wells Fargo, Morgan Stanley. Three major banks recently lowered their price targets for UMB Financial, with JP Morgan and Wells Fargo cutting theirs to $160 and $147 respectively. Morgan Stanley also reduced its target to $182 while maintaining an Overweight rating. These adjustments provide a new baseline for the stock's valuation, which currently trades near its 52-week low.